Toggle Offcanvas
...
 
Alirocumab Tenders

Alirocumab Tenders

View Alirocumab tenders, RFPs and contracts. Bid on readily available Alirocumab tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Alirocumab tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Alirocumab.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Alirocumab market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Alirocumab tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

9 Live Notices for Alirocumab Tenders

Showing 1 to 9

Prescription Service Drug Insurance Supplement Competition
country Saudi Arabia
posting date30 Jan 2025
deadline03 Nov 2025
Medicinal Preparations For The Cardiovascular System Xxii. - Alirocumab
country Czech Republic
posting date10 Jan 2025
deadline11 Feb 2025
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab (C10Ax14) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date14 Jun 2024
deadline31 May 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab (C10Ax14) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date12 Jun 2024
deadline31 May 2026
Completion Of A Non-Excl. Discount Agreement According To § 130A Paragraph 8 Sgb V For Alirocumab, Atc Code: C10Ax14 For The Period From 06/01/2023 To 05/31/2025
country Germany
posting date02 May 2023
deadline04 Apr 2025
Completion Of A Non-Excl. Discount Agreement According To § 130A Paragraph 8 Sgb V For Alirocumab, Atc Code: C10Ax14 For The Period From 06/01/2023 To 05/31/2025
country Germany
posting date28 Apr 2023
deadline04 Apr 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Substance Alirocumab, Atc C10Ax14 For The Period June 1St, 2023 - May 31St, 2025
country Germany
posting date21 Apr 2023
deadline05 Apr 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Substance Alirocumab, Atc C10Ax14 For The Period June 1St, 2023 - May 31St, 2025
country Germany
posting date21 Apr 2023
deadline05 Apr 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Substance Alirocumab, Atc C10Ax14 For The Period June 1St, 2023 - May 31St, 2025
country Germany
posting date21 Apr 2023
deadline05 Apr 2025

Share Share this page